Price Alert

ANI Pharmaceuticals Inc. (ANIP)

NASDAQ: ANIP · Real-Time Price · USD

87.42

-2.58 (-2.87%)

At close: Aug 15, 2025, 3:59 PM

87.47

0.06%

After-hours: Aug 15, 2025, 04:20 PM EDT

-2.87% (1D)

Bid	84.07
Market Cap	1.9B
Revenue (ttm)	674.07M
Net Income (ttm)	-21.05M
EPS (ttm)	-0.69
PE Ratio (ttm)	-126.7
Forward PE	11.69
Analyst	Buy

Ask	91
Volume	824,848
Avg. Volume (20D)	406,775
Open	89.05
Previous Close	90.00
Day's Range	85.44 - 90.14
52-Week Range	52.50 - 90.23
Beta	0.61

About ANIP

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ANIP

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ANIP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

ANI Pharmaceuticals has released their quartely earnings on Aug 8, 2025:

Revenue of $211.37M exceeds estimates by $21.96M, with 53.12% YoY growth.

EPS of 1.8 exceeds estimates by 0.54, with 76.47% YoY growth.

Next Earnings Release

ANI Pharmaceuticals Inc. is scheduled to release its earnings on Nov 7, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

+18.07%

ANI Pharmaceuticals shares are trading higher afte... Unlock content with Pro Subscription

5 months ago

+13.39%

ANI Pharmaceuticals shares are trading higher after the company reported better-than-expected Q4 financial results.

News

4 days ago · zacks.com

ANI (ANIP) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for ANI (ANIP) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wal...

1 week ago · seekingalpha.com

ANI Pharmaceuticals, Inc. (ANIP) Q2 2025 Earnings Call Transcript

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Q2 2025 Earnings Conference Call August 8, 2025 8:30 AM ET Company Participants Christopher K. Mutz - Senior VP & Head of Rare Disease Nikhil Lalwani - Preside...

1 week ago · zacks.com

ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Surpass Estimates

ANI Pharmaceuticals (ANIP) came out with quarterly earnings of $1.8 per share, beating the Zacks Consensus Estimate of $1.38 per share. This compares to earnings of $1.02 per share a year ago.

2 weeks ago · zacks.com

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release

ANI (ANIP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago · zacks.com

Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?

ANI (ANIP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.